Effects of sevelamer and calcium‐based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: A randomized clinical trial

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

Hypertension, Cardiovascular Disease, Endpoint Reduction +7

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

Glenn M. Chertow, Steven K. Burke, Paolo Raggi et al. · Kidney International · 2002 · 1.5K citations · Full text

Thrombosis, Hemodialysis, Urology +13

The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis

Dennis M. Black, Susan L. Greenspan, Kristine E. Ensrud et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

Hyperuricemia in Primary and Renal Hypertension

Paul J. Cannon, William B. Stason, Felix E. Demartini et al. · New England Journal of Medicine · 1966 · 505 citations

Hypertension, Urology, Renal Disease +12

Serum Uric Acid in Essential Hypertension: An Indicator of Renal Vascular Involvement

Franz H. Messerli · Annals of Internal Medicine · 1980 · 464 citations